Silencing Small Nucleolar RNAs (snoRNAs) with Antisense Oligonucleotides (ASOs) for Treatment of Atherosclerosis
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Duke University Medical Center
Award Date
Award Amount
109,837
Program Name
Translational Research Grant
Program Category
Research and Equipment Support
Principal Investigator
Christopher Holley
Fiscal Year
2022
Region
Research Triangle
Project Description:
Duke University Medical Center received $109,837 to design and test RNA-targeting drugs for the treatment of atherosclerosis, which is the leading cause of coronary artery disease and stroke.